Pioneering precision epigenetic medicines
We are hiring passionate, talented moonwalkers. See our open roles.
Our science
By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies are discovered and developed.
First in the field
Moonwalk is the first company to couple an epigenetic discovery platform with precise engineering – opening up the epigenome as a new target space for complex diseases.
Engineering the epigenome
Moonwalk technology brings the most advanced AI prediction of epigenetic targets, and the broadest set of epigenetic engineering tools.
Moonwalk’s focus
Moonwalk’s focus on epigenetic engineering leverages comprehensive read-and-write technologies to develop potentially curative therapies for diseases at the root cause.
Moonwalk's Team
Scientific Advisors
Moonwalk News
August 19, 2024
Moonwalk Biosciences Appoints VP of Biology and Translational Science and Announces Formation of Cardiometabolic Advisory Board
Investors
